{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:19:09Z","timestamp":1792293549865,"version":"4.4.0"},"reference-count":33,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.2967\/jnumed.123.265894","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T17:05:13Z","timestamp":1703178313000},"page":"228-235","source":"Crossref","is-referenced-by-count":26,"title":["Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis"],"prefix":"10.2967","volume":"65","author":[{"given":"Liene","family":"Friebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin T.","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bushnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"2024020105551734000_65.2.228.1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i6.829"},{"key":"2024020105551734000_65.2.228.2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.amjsurg.2020.08.003","article-title":"Comparison of benign and malignant insulinoma","volume":"221","author":"Sada","year":"2021","journal-title":"Am J Surg."},{"key":"2024020105551734000_65.2.228.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2013.07.001"},{"key":"2024020105551734000_65.2.228.4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12902-018-0321-8","article-title":"Clinical management of malignant insulinoma: a single institution\u2019s experience over three decades","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Endocr Disord."},{"key":"2024020105551734000_65.2.228.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.085142"},{"key":"2024020105551734000_65.2.228.6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-19-0989","article-title":"Clinico-pathological features, treatments and survival of malignant insulinomas: a multicenter study","volume":"182","author":"Veltroni","year":"2020","journal-title":"Eur J Endocrinol."},{"key":"2024020105551734000_65.2.228.7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jlcr.3750","article-title":"Exendin-4 analogs in insulinoma theranostics","volume":"62","author":"Jansen","year":"2019","journal-title":"J Labelled Compd Radiopharm."},{"key":"2024020105551734000_65.2.228.8","first-page":"368","article-title":"Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy","volume":"24","author":"de Jong","year":"1997","journal-title":"Eur J Nucl Med."},{"key":"2024020105551734000_65.2.228.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.2151"},{"key":"2024020105551734000_65.2.228.10","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1210\/jc.2018-01991","article-title":"Symptomatic and radiological response to 177Lu-DOTATATE for the treatment of functioning pancreatic neuroendocrine tumors","volume":"104","author":"Zandee","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020105551734000_65.2.228.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1563"},{"key":"2024020105551734000_65.2.228.12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40618-018-0911-3","article-title":"Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review","volume":"42","author":"Magalh\u00e3es","year":"2019","journal-title":"J Endocrinol Invest."},{"key":"2024020105551734000_65.2.228.13","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.4158\/ACCR-2019-0086","article-title":"Long-term effect of 177Lu-DOTATATE on severe and refractory hypoglycemia associated with malignant insulinoma","volume":"5","author":"Iglesias","year":"2019","journal-title":"AACE Clin Case Rep."},{"key":"2024020105551734000_65.2.228.14","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01901"},{"key":"2024020105551734000_65.2.228.15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.14310\/horm.2002.1706","article-title":"Glycemic control in patients with insulinoma","volume":"15","author":"Matej","year":"2016","journal-title":"Hormones (Athens)."},{"key":"2024020105551734000_65.2.228.16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-1101"},{"key":"2024020105551734000_65.2.228.17","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0222"},{"key":"2024020105551734000_65.2.228.18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-1010"},{"key":"2024020105551734000_65.2.228.19","first-page":"140047","article-title":"Intermittent everolimus administration for malignant insulinoma","volume":"2014","author":"Baratelli","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"key":"2024020105551734000_65.2.228.20","doi-asserted-by":"publisher","DOI":"10.1159\/000443171"},{"key":"2024020105551734000_65.2.228.21","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1236916"},{"key":"2024020105551734000_65.2.228.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2024020105551734000_65.2.228.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00572-6"},{"key":"2024020105551734000_65.2.228.24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.2553"},{"key":"2024020105551734000_65.2.228.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009290"},{"key":"2024020105551734000_65.2.228.26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.0702"},{"key":"2024020105551734000_65.2.228.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003825"},{"key":"2024020105551734000_65.2.228.28","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw561"},{"key":"2024020105551734000_65.2.228.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.304"},{"key":"2024020105551734000_65.2.228.30","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0488"},{"key":"2024020105551734000_65.2.228.31","first-page":"610","article-title":"Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq 90Y-DOTATOC","volume":"43","author":"Waldherr","year":"2002","journal-title":"J Nucl Med."},{"key":"2024020105551734000_65.2.228.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2893-5"},{"key":"2024020105551734000_65.2.228.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0691-z"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.265894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T13:58:09Z","timestamp":1706795889000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.265894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.2967\/jnumed.123.265894"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.265894","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]}}}